This event will feature live presentations from life sciences executives addressing various investment opportunities in Biopharma, Biotech, Medtech and Infant Nutrition.
Co-Host
Thursday, June 23rd Agenda
Orexo AB
OTCQX: ORXOY | Nasdaq STO: ORX
Industry: Substance Use Disorder Pharmaceuticals and Digital Therapies
Nikolaj Sørensen, President and CEO
Else Nutrition
OTCQX: BABYF | TSX: BABY
Industry: Plant-Based Nutrition
Hamutal Yitzhak, Co-Founder and CEO
Izotropic Corporation
OTCQB: IZOZF | CSE: IZO
Industry: 3D Breast Cancer Imaging Technology
Dr. John McGraw, CEO
Alterity Therapeutics
NASDAQ: ATHE | ASX: ATH
Industry: Disease Therapy - Neurodegenerative
David Stamler, M.D., CEO
Satellos Bioscience
Pink: MSCLF | TSX-V: MSCL
Industry: Biotech - Skeletal Muscle Regeneration
Frank Gleeson, Founder & CEO
Alpha Cognition Inc.
OTCQB: ACOGF | TSX-V: ACOG
Industry: Biopharma - Neurodegenerative
Michael McFadden, CEO
Emmaus Life Sciences, Inc.
OTCQX: EMMA
Industry: Biopharma - Sickle Cell Disease
Yutaka Niihara, Chief Executive Officer, Chairman of the Board
Reviva Pharmaceuticals
NASDAQ: RVPH
Industry: Biopharma - CNS, Respiratory and Metabolic Diseases
Laxminarayan Bhat, PhD, Founder, CEO and President
John D. Vandermosten, CFA, Zacks Senior Biotech Analyst
Poolbeg Pharma PLC
OTCQB: POLBF | AIM: POLB
Industry: Biopharma - Infectious Diseases
Cathal Friel, Chairman
Jeremy Skillington, CEO
Celsion Corporation
Nasdaq: CLSN
Industry: Biotech - Cancer Research
Khursheed Anwer, EVP & Chief Science Officer
Jeffrey Church, SVP & CFO